REPORT ID 3395

EMEA (Europe, Middle East and Africa) Glucosylceramidase Market Report 2019

Publish Date
2019
Pages
102
Format
Electronic (PDF)

In this report, the EMEA Glucosylceramidase market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Glucosylceramidase for these regions, from   2019 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Glucosylceramidase market competition by top manufacturers/players, with Glucosylceramidase sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Amicus Therapeutics, Inc.
    Bioorganic Research and Services S.A.
    greenovation Biotech GmbH
    JCR Pharmaceuticals Co., Ltd.
    Pharming Group N.V.
    Protalix BioTherapeutics, Inc.
    Shire Plc
    The International Biotechnology Center (IBC) Generium

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    AVRRD-02
    LTI-291
    NCGC-607
    Pcgin
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Genetic Disorders
    Gaucher Disease
    Parkinson's Disease
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Glucosylceramidase Market  Report 2019
1 Glucosylceramidase Overview
    1.1 Product Overview and Scope of Glucosylceramidase
    1.2 Classification of Glucosylceramidase
        1.2.1 EMEA Glucosylceramidase Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 EMEA Glucosylceramidase Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 AVRRD-02
        1.2.4 LTI-291
        1.2.5 NCGC-607
        1.2.6 Pcgin
        1.2.7 Others
    1.3 EMEA Glucosylceramidase Market by Application/End Users
        1.3.1 EMEA Glucosylceramidase Sales (Volume) and Market Share Comparison by Application ( 2014-2024
        1.3.2 Genetic Disorders
        1.3.3 Gaucher Disease
        1.3.4 Parkinson's Disease
        1.3.5 Others
    1.4 EMEA Glucosylceramidase Market by Region
        1.4.1 EMEA Glucosylceramidase Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 Europe Status and Prospect ( 2014-2024)
        1.4.3 Middle East Status and Prospect ( 2014-2024)
        1.4.4 Africa Status and Prospect ( 2014-2024)
    1.5 EMEA Market Size (Value and Volume) of Glucosylceramidase ( 2014-2024)
        1.5.1 EMEA Glucosylceramidase Sales and Growth Rate ( 2014-2024)
        1.5.2 EMEA Glucosylceramidase Revenue and Growth Rate ( 2014-2024)

2 EMEA Glucosylceramidase Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Glucosylceramidase Market Competition by Players/Manufacturers
        2.1.1 EMEA Glucosylceramidase Sales Volume and Market Share of Major Players ( 2014-2019)
        2.1.2 EMEA Glucosylceramidase Revenue and Share by Players ( 2014-2019)
        2.1.3 EMEA Glucosylceramidase Sale Price by Players ( 2014-2019)
    2.2 EMEA Glucosylceramidase (Volume and Value) by Type/Product Category
        2.2.1 EMEA Glucosylceramidase Sales and Market Share by Type ( 2014-2019)
        2.2.2 EMEA Glucosylceramidase Revenue and Market Share by Type ( 2014-2019)
        2.2.3 EMEA Glucosylceramidase Sale Price by Type ( 2014-2019)
    2.3 EMEA Glucosylceramidase (Volume) by Application
    2.4 EMEA Glucosylceramidase (Volume and Value) by Region
        2.4.1 EMEA Glucosylceramidase Sales and Market Share by Region ( 2014-2019)
        2.4.2 EMEA Glucosylceramidase Revenue and Market Share by Region ( 2014-2019)
        2.4.3 EMEA Glucosylceramidase Sales Price by Region ( 2014-2019)

3 Europe Glucosylceramidase (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Glucosylceramidase Sales and Value ( 2014-2019)
        3.1.1 Europe Glucosylceramidase Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 Europe Glucosylceramidase Revenue and Growth Rate ( 2014-2019)
    3.2 Europe Glucosylceramidase Sales and Market Share by Type
    3.3 Europe Glucosylceramidase Sales and Market Share by Application
    3.4 Europe Glucosylceramidase Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Glucosylceramidase Sales Volume by Countries ( 2014-2019)
        3.4.2 Europe Glucosylceramidase Revenue by Countries ( 2014-2019)
        3.4.3 Germany Glucosylceramidase Sales and Growth Rate ( 2014-2019)
        3.4.4 France Glucosylceramidase Sales and Growth Rate ( 2014-2019)
        3.4.5 UK Glucosylceramidase Sales and Growth Rate ( 2014-2019)
        3.4.6 Russia Glucosylceramidase Sales and Growth Rate ( 2014-2019)
        3.4.7 Italy Glucosylceramidase Sales and Growth Rate ( 2014-2019)
        3.4.8 Benelux Glucosylceramidase Sales and Growth Rate ( 2014-2019)

4 Middle East Glucosylceramidase (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Glucosylceramidase Sales and Value ( 2014-2019)
        4.1.1 Middle East Glucosylceramidase Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Middle East Glucosylceramidase Revenue and Growth Rate ( 2014-2019)
    4.2 Middle East Glucosylceramidase Sales and Market Share by Type
    4.3 Middle East Glucosylceramidase Sales and Market Share by Application
    4.4 Middle East Glucosylceramidase Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Glucosylceramidase Sales Volume by Countries ( 2014-2019)
        4.4.2 Middle East Glucosylceramidase Revenue by Countries ( 2014-2019)
        4.4.3 Saudi Arabia Glucosylceramidase Sales and Growth Rate ( 2014-2019)
        4.4.4 Israel Glucosylceramidase Sales and Growth Rate ( 2014-2019)
        4.4.5 UAE Glucosylceramidase Sales and Growth Rate ( 2014-2019)
        4.4.6 Iran Glucosylceramidase Sales and Growth Rate ( 2014-2019)

5 Africa Glucosylceramidase (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Glucosylceramidase Sales and Value ( 2014-2019)
        5.1.1 Africa Glucosylceramidase Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 Africa Glucosylceramidase Revenue and Growth Rate ( 2014-2019)
    5.2 Africa Glucosylceramidase Sales and Market Share by Type
    5.3 Africa Glucosylceramidase Sales and Market Share by Application
    5.4 Africa Glucosylceramidase Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Glucosylceramidase Sales Volume by Countries ( 2014-2019)
        5.4.2 Africa Glucosylceramidase Revenue by Countries ( 2014-2019)
        5.4.3 South Africa Glucosylceramidase Sales and Growth Rate ( 2014-2019)
        5.4.4 Nigeria Glucosylceramidase Sales and Growth Rate ( 2014-2019)
        5.4.5 Egypt Glucosylceramidase Sales and Growth Rate ( 2014-2019)
        5.4.6 Algeria Glucosylceramidase Sales and Growth Rate ( 2014-2019)

6 EMEA Glucosylceramidase Manufacturers/Players Profiles and Sales Data
    6.1 Amicus Therapeutics, Inc.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Glucosylceramidase Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Amicus Therapeutics, Inc. Glucosylceramidase Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 Bioorganic Research and Services S.A.
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Glucosylceramidase Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Bioorganic Research and Services S.A. Glucosylceramidase Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 greenovation Biotech GmbH
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Glucosylceramidase Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 greenovation Biotech GmbH Glucosylceramidase Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 JCR Pharmaceuticals Co., Ltd.
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Glucosylceramidase Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 Pharming Group N.V.
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Glucosylceramidase Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Pharming Group N.V. Glucosylceramidase Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 Protalix BioTherapeutics, Inc.
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Glucosylceramidase Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Protalix BioTherapeutics, Inc. Glucosylceramidase Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Shire Plc
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Glucosylceramidase Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Shire Plc Glucosylceramidase Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 The International Biotechnology Center (IBC) Generium
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Glucosylceramidase Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview

7 Glucosylceramidase Manufacturing Cost Analysis
    7.1 Glucosylceramidase Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Glucosylceramidase

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Glucosylceramidase Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Glucosylceramidase Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Glucosylceramidase Market Forecast ( 2019-2025)
    11.1 EMEA Glucosylceramidase Sales, Revenue and Price Forecast ( 2019-2025)
        11.1.1 EMEA Glucosylceramidase Sales and Growth Rate Forecast ( 2019-2025)
        11.1.2 EMEA Glucosylceramidase Revenue and Growth Rate Forecast ( 2019-2025)
        11.1.3 EMEA Glucosylceramidase Price and Trend Forecast ( 2019-2025)
    11.2 EMEA Glucosylceramidase Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.3 Europe Glucosylceramidase Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.4 Middle Eastt Glucosylceramidase Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.5 Africa Glucosylceramidase Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.6 EMEA Glucosylceramidase Sales Forecast by Type ( 2019-2025)
    11.7 EMEA Glucosylceramidase Sales Forecast by Application ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer